From AI to Precision Medicine: Taiwan’s Smart Healthcare Innovations Shine at Taiwan Expo USA 2025
DALLAS, Aug. 5, 2025 /PRNewswire/ -- The Smart Healthcare Pavilion at Taiwan Expo USA 2025 will take place at the...
Brain
13 Women-Led Tech Startups Join FourthWave’s 2025 Accelerator Program
Thirteen women-led tech startups have been selected to participate in FourthWave's 16-week 2025 accelerator program that provides founders with one-on-one...
Dentistry’s iPhone Moment: Trust AI Raises $6M, Transforming How 200,000 Dentists in the U.S. Practice
SAN FRANCISCO, Aug. 5, 2025 /PRNewswire/ -- Trust AI, the 'ChatGPT' for dentists, has raised $6 million, the largest seed...
The Dr. Gundry Podcast, Hosted by Dr. Steven Gundry, Surpasses One Million Subscribers on YouTube
Known for Gut Health Insights, Olive Oil Advocacy, and Myth-Busting Advice, The Dr. Gundry Podcast Has Surpassed One Million Subscribers...
HMNC Brain Health Announces Phase 2 Results from OLIVE Trial in Major Depressive Disorder (MDD) with Genetically Guided Precision Approach
BH-200 (nelivaptan) achieved clinically meaningful reduction in depressive symptoms across the full study population (Difference between BH-200 and placebo in...
Bioma Probiotics Launches Science-Backed Gut Health Formula for Women’s Natural Weight Loss
Discover how Bioma Probiotics supports weight loss, balances gut health, and helps women reduce bloating, boost energy, and improve digestion...
Dxcover Strengthens Leadership with World-Class Scientific Advisors and Board Members
Company assembles a globally renowned team of clinical and corporate experts to drive commercial expansion, scale its multi-cancer testing platform,...
Dxcover Strengthens Leadership with World-Class Scientific Advisors and Board Members
Company assembles a globally renowned team of clinical and corporate experts to drive commercial expansion, scale its multi-cancer testing platform,...
Digital Therapeutics Market to Grow at a CAGR of 26.3% from 2025 to 2032 | SkyQuest Technology Consulting
The digital therapeutics market is anticipated to increase due to the growing global burden of chronic conditions such as diabetes,...
Children’s Hospital Colorado’s Gait Lab Now Offers State-of-the-Art Camera Technology
Updated technology allows for better data resolution; helps with quicker diagnosis, results and patient recovery AURORA, Colo., Aug. 4, 2025...
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System
NEURO PMR study evaluates the clinical utility and patient experience of AI-powered portable MRI in an outpatient settingGUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine,...
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System
NEURO PMR study evaluates the clinical utility and patient experience of AI-powered portable MRI in an outpatient settingGUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine,...
Corporate Update, August 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- From Dr. Neil Maresky, CEO, Psyence BioMed (NASDAQ: PBM) Dear Shareholders, Thank...
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in seizure frequency...
Praxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of Vormatrigine
Dosing with vormatrigine over 8 weeks led to 56.3% median reduction in seizure frequency Approximately 22% of patients reached 100%...
IPG Health Introduces the Future of Market Research with ‘LivingMirror,’ an Always-On AI Focus Group for Healthcare
Expanding network’s proprietary EPICC suite of tools for secure, AI-powered replicas of both HCPs and patientsNEW YORK, Aug. 01, 2025...
Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives
HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader...
Cells: Hemostemix ACP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants
Calgary, Alberta--(Newsfile Corp. - July 31, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is...
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a...
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a...